TFRC and neoplasm: To this end, we grouped the study cohort according to the tumor size and did not find any difference between patients with localized (pT1 and pT2, n = 38) and locally advanced (pT3 and pT4, n = 15) tumors with respect to the MFI of CD71 on neutrophils.